Pooled testing of sputum with Xpert MTB/RIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao People's Democratic Republic



Iem, Vibol, Chittamany, Phonenaly, Suthepmany, Sakhone, Siphanthong, Souvimone, Siphanthong, Phitsada, Somphavong, Silaphet, Kontogianni, Konstantina, Dodd, James, Khan, Jahangir Am, Dominguez, Jose
et al (show 3 more authors) (2022) Pooled testing of sputum with Xpert MTB/RIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao People's Democratic Republic. BMJ GLOBAL HEALTH, 7 (2). e007592-.

Access the full-text of this item by clicking on the Open Access link.
[img] PDF
Pooled testing of sputum with Xpert MTBRIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao Peoples .pdf - Published version

Download (1MB) | Preview

Abstract

<h4>Introduction</h4>Active case finding (ACF) of individuals with tuberculosis (TB) is a key intervention to find the 30% of people missed every year. However, ACF requires screening large numbers of individuals who have a low probability of positive results, typically <5%, which makes using the recommended molecular tests expensive.<h4>Methods</h4>We conducted two ACF surveys (in 2020 and 2021) in high TB burden areas of Lao PDR. Participants were screened for TB symptoms and received a chest X-ray. Sputum samples of four consecutive individuals were pooled and tested with Xpert Mycobacterium tuberculosis (MTB)/rifampicin (RIF) (Xpert-MTB/RIF) (2020) or Xpert-Ultra (2021). The agreement of the individual and pooled samples was compared and the reasons for discrepant results and potential cartridge savings were assessed.<h4>Results</h4>Each survey included 436 participants, which were tested in 109 pools. In the Xpert-MTB/RIF survey, 25 (sensitivity 89%, 95% CI 72.8% to 96.3%) of 28 pools containing MTB-positive samples tested positive and 81 pools containing only MTB-negative samples tested negative (specificity 100%, 95% CI 95.5% to 100%). In the Xpert-Ultra survey, all 32 (sensitivity 100%, 95% CI 89.3% to 100%) pools containing MTB-positive samples tested positive and all 77 (specificity 100%, 95% CI 95.3% to 100%) containing only MTB-negative samples tested negative. Pooling with Xpert-MTB/RIF and Xpert-Ultra saved 52% and 46% (227/436 and 199/436, respectively) of cartridge costs alone.<h4>Conclusion</h4>Testing single and pooled specimens had a high level of agreement, with complete concordance when using Xpert-Ultra. Pooling samples could generate significant cartridge savings during ACF campaigns.

Item Type: Article
Uncontrolled Keywords: Xpert MTB, RIF, Xpert Ultra, pooling, pooled testing, active case finding
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 20 Jan 2023 10:05
Last Modified: 06 Apr 2023 10:02
DOI: 10.1136/bmjgh-2021-007592
Open Access URL: http://dx.doi.org/10.1136/bmjgh-2021-007592
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3167185